DaVita
DVA
#1958
Rank
NZ$17.12 B
Marketcap
NZ$256.12
Share price
1.19%
Change (1 day)
-0.04%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2025 (TTM): NZ$17.32

According to DaVita's latest financial reports the company's current EPS (TTM) is NZ$17.28. In 2024 the company made an earnings per share (EPS) of NZ$18.84 an increase over its 2023 EPS that were of NZ$13.00.

EPS history for DaVita from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$17.32-8.03%
2024NZ$18.8444.94%
2023NZ$13.0027.26%
2022NZ$10.21-35.56%
2021NZ$15.8544.1%
2020NZ$11.0019.7%
2019NZ$9.19540.48%
2018NZ$1.43-76.07%
2017NZ$5.99-19.31%
2016NZ$7.43242.52%
2015NZ$2.17-62.87%
2014NZ$5.8413.43%
2013NZ$5.158.45%
2012NZ$4.75

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
NZ$36.46 110.97%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$17.50 1.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
NZ$25.10 45.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
NZ$3.24-81.24%๐Ÿ‡บ๐Ÿ‡ธ USA